A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : 6MWD / 6-minute walk distance

[Related PubMed/MEDLINE]
Total Number of Papers: 946
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   6MWD  (>> Co-occurring Abbreviation)
Long Form:   6-minute walk distance
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A 1-Month Physical Therapy-Based Outpatient Program for Adults Awaiting Lung Transplantation: A Retrospective Analysis of Exercise Capacity, Symptoms, and Quality of Life. CES-D, PT, QOL, SOBQ
2019 Airway wall thickening on CT: Relation to smoking status and severity of COPD. SGRQ
2019 Are Walking Treatment Beliefs and Illness Perceptions Associated With Walking Intention and 6-Min Walk Distance in People With Intermittent Claudication? A Cross-Sectional Study. ---
2019 Clinical and imaging manifestations of Takayasu's arteritis with pulmonary hypertension: A retrospective cohort study in China. PH, PTA
2019 Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension. NT-proBNP, PH, RHC, SAPH
2019 Comparing modalities of conducting the six-minute walk test in healthy children and adolescents. 6MWT
2019 Do Postoperative Results Differ in a Randomized Trial Between a Direct Anterior and a Direct Lateral Approach in THA? HHS, OHS
2019 Effects of community-based pulmonary rehabilitation in 33 municipalities in Denmark - results from the KOALA project. HRQoL, PR
2019 Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: A randomised controlled trial. CF, IMT, LOS, MEP, MIP, PT
10  2019 Effects of Postacute Multidisciplinary Rehabilitation Including Exercise in Out-of-Hospital Settings in the Aged: Systematic Review and Meta-analysis. CI, OOHS
11  2019 Effects of postoperative dietary intake on functional recovery of patients undergoing cardiac surgery. DI
12  2019 Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials. BNP, CI, HFmrEF, HFpEF, HFrEF, MD, NYHA FC, OR, PIIINP, RCTs, SMD
13  2019 Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis. ---
14  2019 Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study. BNP, IRRID, PAH
15  2019 Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study. BOS
16  2019 Exercise-Induced Oxygen Desaturation as a Predictive Factor for Longitudinal Decline in 6-Minute Walk Distance in Subjects With COPD. EID
17  2019 HIV infection is an independent risk factor for decreased 6-minute walk test distance. FVC, PLWH, SGRQ
18  2019 Impact of breathing exercises in subjects with lung cancer undergoing surgical resection: A systematic review and meta-analysis. LOS, PPCs, RCTs
19  2019 Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. CTEPH, CW, FC, NT-proBNP
20  2019 Long-term Outcome of Metallic Stenting For Central Airway Involvement In Relapsing Polychondritis. mMRC
21  2019 Longitudinal assessment of exercise capacity and quality of life outcome measures in cystic fibrosis: A year-long prospective pilot study. CF, CFQ-R, MCID
22  2019 Maintenance Negative Pressure Ventilation Improves Survival in COPD Patients with Exercise Desaturation. 6MWT, CI, COPD, HR, NPV
23  2019 Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial. HRQoL, IG, ITT, mITT, UC
24  2019 Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study. ILD, TTR
25  2019 Osteoarthritis-Related Walking Disability and Arterial Stiffness: Results From a Cross-Sectional Study. CVD, OA
26  2019 Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension at a Single Center in Taiwan. CTEPH, FC, PEA
27  2019 Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial). HFpEF, NEAT, NT-proBNP
28  2019 Pulmonary arterial hypertension in Saudi patients with systemic sclerosis: Clinical and hemodynamic characteristics and mortality. CI, OR, PAH, RHC, RP, SSc
29  2019 Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis. CTEPH, NYHA, PAH, TPG
30  2019 Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study. LPH, PAH, PROs, SD, WHO-FC
31  2019 Risk Analysis of Perioperative Death in Lung Transplant Patients With Severe Idiopathic Pulmonary Hypertension. CI, IPAH, NT-proBNP
32  2019 Safety and feasibility of electrical muscle stimulation in patients undergoing autologous and allogeneic stem cell transplantation or intensive chemotherapy. EMS, MFI, QOL, SPPB
33  2019 Supervised exercise training with multimodal pre-habilitation leads to earlier functional recovery following colorectal cancer resection. 6MWT, pre-habilitation, RCT
34  2019 Supplemented amino acids may enhance the walking recovery of elderly subjects after hip fracture surgery. EAAs, HFS, RP
35  2019 Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. PH, SMR, SSc, SStc
36  2019 The Efficacy and Safety of Aerosolized Iloprost in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. CIs, PAH
37  2019 The efficacy and safety of pulmonary vasodilators in patients with Fontan circulation: a meta-analysis of randomized controlled trials. BNP, mPAP, NYHA
38  2019 Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension. DPG, FC, HFpEF, Ipc-PH, PH, PVR
39  2019 Trimetazidine in angina and poor muscle function (TAP): protocol for a randomized controlled study. FTSST, GS, HS, TAP, TMZ, TST
40  2018 A comparative study of the five-repetition sit-to-stand test and the 30-second sit-to-stand test to assess exercise tolerance in COPD patients. 30STS, QMS, STST
41  2018 A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension. ES, ET, PAH
42  2018 A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension. mRASP, PAH, RAA, WHO-FC
43  2018 A retrospective study of Yiqibushenhuoxue decoction for the treatment of chronic obstructive pulmonary disease. 6MWT, AEs, COPD, FEV1, FVC, SGRQ, YQBSHXD
44  2018 Adaptive servo-ventilation to treat central sleep apnea in heart failure with reduced ejection fraction: the BadOeynhausen prospective ASV registry. AHI, ASV, CPX, CSA, HFREF, LVEF
45  2018 Aerobic With Resistance Training or Aerobic Training Alone Poststroke: A Secondary Analysis From a Randomized Clinical Trial. VO2VT
46  2018 Assessment of anti-reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux. AECOPD, COPD, GER, TNF-alpha
47  2018 Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertension. PAH, RAP
48  2018 Association between Pulmonary Function and Stair-Climbing Test Results after Lung Resection: A Pilot Study. ---
49  2018 Association of comorbid anxiety and depression with chronic obstructive pulmonary disease. BMI, CCQ, COPD, FEV1, mMRC
50  2018 Bendopnea and Its Clinical Importance in Outpatient Patients with Pulmonary Arterial Hypertension. HF, NT-proBNP, PAH, RV, WHO
51  2018 Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study. CMRI, PAH, RHC
52  2018 Cessation of pacing in super-responders of cardiac resynchronization therapy: A randomized controlled trial. CRT, LVEDV, LVEF, LVESV, NYHA, QOL
53  2018 Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease. BETs, NYHA FC, PVR, SCD
54  2018 Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. FVC, mPAP, PAWP, PH, PVR, RHC, SAPH, US
55  2018 Clinical outcomes with biventricular versus right ventricular pacing in patients with atrioventricular conduction defects. BiV, CI, HF, RCTs, RR, RV
56  2018 Comparison between the efficacy of combination therapy and monotherapy in connective tissue disease associated pulmonary arterial hypertension: a systematic review and meta-analysis. CI, CTD, PAH, RCTs
57  2018 Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China. GOLD
58  2018 Complications related to endoscopic lung volume reduction for emphysema with endobronchial valves: results of a multicenter study. BLVR, COPD, MCID, RV, SGRQ, TLVR
59  2018 Cost-effectiveness of endobronchial valve treatment in patients with severe emphysema compared to standard medical care. EBV, EQ5D, ICER, QALY, SGRQ
60  2018 Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial. CL, nmDMD
61  2018 Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease. CWRT
62  2018 Determining the minimally important difference in quadriceps strength in individuals with COPD using a fixed dynamometer. HADS, MID, PRP, QMVC, SGRQ
63  2018 Diaphragm Muscle Dysfunction in Patients With Heart Failure. HF
64  2018 Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial. ESRD, QOL
65  2018 Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A Randomized Clinical Trial. ---
66  2018 Effect of Liuzijue Exercise Combined with Elastic Band Resistance Exercise on Patients with COPD: A Randomized Controlled Trial. 30 s SST, 6MWT, CG, COPD, LEG, LG, SGRQ
67  2018 Effectiveness of a 4-week rehabilitation program on endothelial function, blood vessel elasticity in patients with chronic obstructive pulmonary disease. AIx, BHT, CAT, COPD, CWE, DAI, GS, MIP, PWV
68  2018 Effectiveness of meditative movement on COPD: a systematic review and meta-analysis. FEV1, MD
69  2018 Effectiveness of pulmonary rehabilitation and correlations in between functional parameters, extent of thoracic surgery and severity of post-operative complications: randomized clinical trial. 6MWT, BHT, COPD, CWE, GS
70  2018 Effectiveness of pulmonary rehabilitation in COPD patients receiving long-term oxygen therapy. LTOT, LTOT, PR, QOL
71  2018 Effectiveness of Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease With Different Degrees of Static Lung Hyperinflation. COPD, CWRT, LH, PR, RV, SGRQ
72  2018 Effects of comprehensive pulmonary rehabilitation therapy on pulmonary functions and blood gas indexes of patients with severe pneumonia. FEV1
73  2018 Effects of Hochuekkito combined with pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. CAT, COPD, HRQoL, PR, VAS
74  2018 Effects of inspiratory muscle training in chronic heart failure patients: A systematic review and meta-analysis. CHF, IMT, WMD
75  2018 Effects of Remote Ischaemic Conditioning on Heart Rate Variability and Cardiac Function in Patients With Mild Ischaemic Heart Failure. BNP, HRV, IHF, LVEF, RIC
76  2018 Efficacy and safety of a calcium sensitizer, levosimendan, in patients with right heart failure due to pulmonary hypertension. PH, RHF, WHO-FC
77  2018 Efficacy and tolerability of pharmacological interventions for pulmonary arterial hypertension: A network meta-analysis. CI, CW, EAP, ERA, FCA, mPAP, mRAP, NMA, PAH, PDE-5Is, PGI, PVR
78  2018 Efficacy of heart failure reversal treatment in patients with low ejection fraction. CHF, EF, HFRT, MAC
79  2018 Efficacy of patients' preferred exercise modalities in chronic obstructive pulmonary disease: A parallel-group, randomized, clinical trial. COPD, HRQoL, ITT, PPEMs, SGRQ
80  2018 Efficiency of the home cardiac rehabilitation program for adults with complex congenital heart disease. CPET, CWRET
81  2018 Endobronchial coil therapy in severe emphysema: 6-month outcomes from a Swiss National Registry. MCID, RV, SAE, SGRQ
82  2018 Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension. PAH, PAHTCH, PH, PVR, RVSP
83  2018 Evaluation of supervised multimodal prehabilitation programme in cancer patients undergoing colorectal resection: a randomized control trial. ERAS
84  2018 Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. EC, MVA, QOL, UVA
85  2018 Factors predicting outcome after pulmonary endarterectomy. CO, PEA, PVR
86  2018 First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results. AER, BMI, CFTR, FEV1, FVC, LUM/IVA, RAEs
87  2018 Frailty: A global measure of the multisystem impact of COPD. CGA, COPD, FI
88  2018 Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study. AML, FEV1, LAM, SGRQ, VEGF-D
89  2018 Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies. 9HPT, BBS, FSS, HRQoL, ICF, IPA, MAG, MCS, MRC, PCS, SF-36, SMS, VAS
90  2018 Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension. AUC, PAH, RHC, SSc, SVI
91  2018 Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up. CAT, COPD, EC
92  2018 Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study. CAMPHOR, HRQoL, NHP, PAH, pcPH, PH, PROM, QOL, WHO-FC
93  2018 Home Exercise Training Improves Exercise Capacity in Cirrhosis Patients: Role of Exercise Adherence. HET
94  2018 Home-based cardiac rehabilitation improves quality of life, aerobic capacity, and readmission rates in patients with chronic heart failure. CPET, HF, LVEF, MLHFQ, QOL
95  2018 Home-based telehealth exercise training program in Chinese patients with heart failure: A randomized controlled trial. HF, HR, LVEF, NYHA, QOL
96  2018 Impact of Balloon Pulmonary Angioplasty on Hemodynamics and Clinical Outcomes in Patients with Chronic Thromboembolic Pulmonary Hypertension: the Initial Korean Experience. BPA, CTEPH, PEA, WHO
97  2018 Impact of Nocturnal Noninvasive Ventilation on Pulmonary Rehabilitation in Patients with End-Stage Lung Disease Awaiting Lung Transplantation. NIV, PR, SF
98  2018 Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension. 6MWT, HRQoL, NYHA, PAH, QOL
99  2018 Improved 6 Minute Walk Distance and Brain-Type Natriuretic Peptide After Continuous-Flow Ventricular Assist Device Placement in Children. BNP, CF-VAD
100  2018 Individual approach to the treatment of obese copd patients can reduce anthropometric indicators, the level of systemic inflammation and improve the quality of life. BMI, COPD, CRP, IL-26, QL, WC